A patent is a government-granted monopoly. Here's how companies turn that monopoly into billions — through licensing, litigation, patent pools, and the rise of patent assertion entities (patent trolls) that exist solely to extract settlements.
Educational content only — not personalized financial, legal, or tax advice.
A patent is one of the most valuable legal instruments in modern commerce: a government-granted, time-limited monopoly on an invention. For 20 years from the filing date, the patent holder has the exclusive right to make, use, sell, and import the patented invention. Anyone else who does so without a license infringes and may be sued for damages.
The economic rationale for patents is a trade-off: the inventor discloses their invention publicly (enabling others to learn from it and build upon it after expiry), and in exchange receives a period of exclusive commercial exploitation. The theory is that without this temporary monopoly, inventors would either not invest in innovation (if competitors could immediately copy it) or keep inventions secret (if disclosure would eliminate any return).
In practice, the patent system has evolved into something more complex: a tool for competitive exclusion, a revenue-generating asset class divorced from production, and a battlefield where companies with large patent portfolios have structural advantages over those without.
This connects to how copyright works and generates income over decades and to the full picture of intellectual property as a business asset.
Patent licensing is the practice of allowing others to use a patent in exchange for royalty payments. Licensing creates revenue from intellectual property without requiring the patent holder to manufacture or sell anything.
Running royalties are the most common licensing structure: a percentage of the licensee's revenue or a per-unit fee on every product containing the patented technology. ARM Holdings licenses processor architecture designs on a per-chip royalty basis — every smartphone chip using ARM architecture pays ARM a royalty estimated at $0.50-$2.00 per chip. With approximately 30 billion ARM-architecture chips shipped annually, this generates royalty revenue of $2-4 billion per year from technology that costs nothing to reproduce.
Lump-sum licenses exchange a single upfront payment for perpetual rights to a patent or patent portfolio. Large companies settling patent disputes often prefer lump-sum payments to ongoing royalty monitoring obligations.
Cross-licenses are mutual licenses where two companies grant each other access to their patent portfolios. Large technology and semiconductor companies routinely cross-license with each other: Samsung and Apple have cross-license agreements covering thousands of patents. Cross-licensing avoids costly litigation while allowing both parties to use each other's patented technologies.
In industries that rely on technical standards — telecommunications (4G, 5G, Wi-Fi, Bluetooth), video compression (H.264, H.265), and others — patents covering technologies essential to implementing the standard are uniquely powerful.
A standard essential patent (SEP) is a patent that must be used to implement a technical standard. If you manufacture a 4G smartphone, you must implement the 4G standard, which means you must use the patented technologies included in it — technologies owned by Qualcomm, Ericsson, Nokia, Samsung, and others.
SEP holders are uniquely positioned: implementers must license or infringe. To prevent SEP holders from extracting monopoly royalties from this captive audience, standards bodies require SEP holders to commit to licensing on FRAND terms: Fair, Reasonable, and Non-Discriminatory.
What 'fair and reasonable' means is litigated constantly. Qualcomm has faced regulatory action in the U.S., EU, South Korea, Taiwan, and China for allegedly charging above-FRAND royalties and requiring phone manufacturers to pay royalties on the entire phone's value rather than the component implementing the patented technology. The ongoing Qualcomm disputes illustrate how SEP licensing has become a multi-billion dollar strategic battlefield.
A patent assertion entity (PAE), colloquially called a 'patent troll,' is an entity that acquires patents not to use in products or services but solely to assert them against others to extract licensing fees or litigation settlements.
The business model: acquire patents (from bankrupt companies, inventors, or on the secondary market), identify companies whose products plausibly infringe, send licensing demand letters or file lawsuits, and collect settlements that are below the cost of litigation. The defendants typically settle even against weak patents because the cost of defending a patent lawsuit — $2-5 million through trial — exceeds the cost of settling.
PAE activity peaked in 2013-2014, when PAEs accounted for approximately 67% of all U.S. patent litigation. Legislative (America Invents Act 2011, creating IPR proceedings that allow cheaper administrative patent challenges) and judicial (Alice Corp. v. CLS Bank 2014, limiting software patent scope) changes reduced but did not eliminate PAE activity.
Institutional PAEs have become more sophisticated: Intellectual Ventures (funded by Microsoft, Intel, and others) assembled a portfolio of 70,000+ patents and licenses extensively. Acacia Research and InterDigital are publicly traded companies whose primary business is patent licensing and litigation. The distinction between productive companies that license their IP and pure PAEs has blurred as established operating companies have spun out patent licensing divisions.
Patent pools — collective licensing arrangements where multiple patent holders pool their SEPs and offer joint licenses — are the primary market structure response to the SEP licensing problem.
Via Licensing (now Avanci for wireless), MPEG LA, and similar pools offer licensees a single license covering multiple patent holders' SEPs at a negotiated rate. The pool simplifies licensing for implementers and distributes royalty income among pool members based on an agreed formula.
Patent pools face their own tensions: determining which patents are truly essential (and thus eligible for inclusion and royalty sharing) requires expert review. Pool rates must be negotiated among parties with competing interests. Large patent holders may find better terms by licensing independently, creating free-rider problems for pools that don't achieve comprehensive coverage.